Product Information
NUCYNTA 75 MG TABLET is a brand product labeled by Collegium Pharmaceutical, Inc., priced at $11.8592 per EA under NDC 24510007510. Its NADAC has been published 283 times since Aug 7, 2019.
FDA first approved this application on Nov 20, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Collegium Pharmaceutical, Inc.NDC
24510007510
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/18/2024
Active Ingredients
TAPENTADOL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022304FDA Approved
11/20/2008
TE Code
AB
On Market Since
4/1/2019
Pharmacological Classes
Price Statistics
The NADAC for NUCYNTA 75 MG TABLET has been published 283 times since Aug 7, 2019, and over the history we have for it it has risen 66.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8592 per EA |
|---|---|
| All-time high | $11.8633 (Jun 12, 2024) |
| All-time low | $7.1448 (Aug 7, 2019) |
| Median price | $9.9115 |
| Average price | $9.5842 |
| Largest weekly change | +15.0% (Jan 12, 2022) |
| Weeks tracked | 283 |
| Tracking since | Aug 7, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+9.8%
5Y
+38.3%
All
+66.0%
Last surveyed Jan 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the tapentadol hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Collegium Pharmaceutical, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tapentadol hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NUCYNTA 75 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NUCYNTA 75 MG TABLET, manufactured by Collegium Pharmaceutical, Inc., is $11.8592 per EA (NDC 24510007510), effective Jan 1, 2025.
How has the price of NUCYNTA 75 MG TABLET changed over time?
Over the history we have for it, the NADAC for NUCYNTA 75 MG TABLET has risen 66.0%. It has been tracked across 283 weekly CMS publications since Aug 7, 2019.
What are the highest and lowest recorded NADAC prices for NUCYNTA 75 MG TABLET?
Since Aug 7, 2019, the NADAC for NUCYNTA 75 MG TABLET has ranged from a low of $7.1448 (Aug 7, 2019) to a high of $11.8633 (Jun 12, 2024), with a median of $9.9115 per EA.
Are there cheaper alternatives to NUCYNTA 75 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NUCYNTA 75 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NUCYNTA 75 MG TABLET?
NUCYNTA 75 MG TABLET (NDC 24510007510) is labeled by Collegium Pharmaceutical, Inc., and CMS classifies it as a brand product.